SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-098564
Filing Date
2024-09-10
Accepted
2024-09-10 15:30:45
Documents
15
Period of Report
2024-09-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2423380d1_8k.htm   iXBRL 8-K 41645
2 EXHIBIT 3.1 tm2423380d1_ex3-1.htm EX-3.1 196323
  Complete submission text file 0001104659-24-098564.txt   547582

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abbv-20240906.xsd EX-101.SCH 5501
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20240906_def.xml EX-101.DEF 30265
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20240906_lab.xml EX-101.LAB 45153
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20240906_pre.xml EX-101.PRE 28469
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2423380d1_8k_htm.xml XML 11868
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 241289920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)